Dk. Luttrell et al., INVOLVEMENT OF PP60(C-SRC) WITH 2 MAJOR SIGNALING PATHWAYS IN HUMAN BREAST-CANCER, Proceedings of the National Academy of Sciences of the United Statesof America, 91(1), 1994, pp. 83-87
The phosphotyrosine residues of receptor tyrosine kinases serve as uni
que binding sites for proteins involved in intracellular signaling, wh
ich contain SRC homology 2 (SH2) domains. Since overexpression or acti
vation of the pp60c-src kinase has been reported in a number of human
tumors, including primary human breast carcinomas, we examined the int
eractions of the SH2 and SH3 domains of human SRC with target proteins
in human carcinoma cell lines. Glutathione S-transferase fusion prote
ins containing either the SH2, SH3, or the entire SH3/SH2 region of hu
man SRC were used to affinity purify tyrosine-phosphorylated proteins
from human breast carcinoma cell lines. We show here that in human bre
ast carcinoma cell lines, the SRC SH2 domain binds to activated epider
mal growth factor receptor (EGFR) and p185HER2/neu. SRC SH2 binding to
EGFR was also observed in a nontumorigenic cell line after hormone st
imulation. Endogenous pp60c-src was found to tightly associate with ty
rosine-phosphorylated EGFR. Association of the SRC SH2 with the EGFR w
as blocked by tyrosyl phosphopeptides containing the sequences surroun
ding tyrosine-530, the regulatory site in the SRC C terminus, or seque
nces surrounding the major sites of autophosphorylation in the EGFR. T
hese results raise the possibility that association of pp60c-src with
these receptor tyrosine kinases is an integral part of the signaling e
vents mediated by these receptors and may contribute to malignant tran
sformation.